Business Editors
ADVISORY...
--(BUSINESS WIRE)
TOPIC: The Food and Drug Administration (FDA) is investigating whether some popular antidepressants are linked to suicide, according to an article by The Associated Press. The FDA is asking manufacturers of 10 such drugs
EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:
Daniel G. Amen, MD, is a board-certified child and adult psychiatrist, brain imaging specialist, and the chief executive officer of The Amen Clinics in Newport Beach and Fairfield, California and Tacoma, Washington. He is a nationally recognized expert in the fields of neuropsychiatry, or the study of the brain and behavior, and attention deficit disorders. Dr. Amen has pioneered the use of brain imaging in clinical psychiatric practice. His clinics have the world's largest database of functional brain scans for neuropsychiatry. Dr. Amen is Assistant Clinical Professor of Psychiatry and Human Behavior in the University of California, Irvine College of Medicine. Dr. Amen did his general psychiatric training at the Walter Reed Army Medical Center in Washington, DC and his child and adolescent psychiatry training at Trifler Army Medical Center in Honolulu, Hawaii. He can discuss the issue of treating depression. 949-887-8315 docamen@aol.com
Professor Anthony (Tony) Scioli, of the University of New Hampshire, has expertise in psychological testing, and the assessment of depression, suicide, hopelessness. 603-358-2541
Professor Debra VanderVoort, of the University of Hawaii, Hilo, Social Sciences Division Department of Psychology, is a counseling psychologist who specializes in treatment of depression and anxiety. 808-974-7402
ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.
ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.